Europe Air Ambulance Services Market | How has COVID-19 affected the market?

SAN FRANCISCO, CA, US, September 22, 2021 /EINPresswire.com/ — Technological advancements in the online booking of medical mobile vehicles are creating growth prospects in the Europe air ambulance services market. The mechanical headways, increasing geriatric population, and increasing commonness of constant issues are driving growth opportunities in the European air ambulance services market.

The European air ambulance services market is divided on the basis of country, model, and type. As per segmentation on the basis of country, the market is divided into Germany, U.K., France, Italy, and Spain. Furthermore, on the basis of the model, the European air ambulance services market is classified into hospital-based and community-based. Based on type, the European air ambulance services market is bifurcated into rotary-wing and fixed-wing.

The European air ambulance services market is categorized based on type, model, and country. In terms o type, the market is divided into fixed-wing and rotary-wing. Based on classification by model, the market is split into community-based, and hospital-based. As per segmentation by country, the European air ambulance services market is grouped into Spain, Italy, France, U.K., Germany.

Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7593

The report is based on a comprehensive overview of the air ambulance services in Europe with prime emphasis on growth drivers, restraints, upcoming opportunities, and challenges. It also focuses on the impact of the novel covid19 pandemic on this market and how can manufacturers benefit from this situation to obtain as much revenue as possible. The report also discusses the recent trends and opportunities that have shaped the market in the recent past and innovations that will help generate higher revenues for this market in the coming years. The table of segmentation, the name of the leading segment, and its attributing factors are all discussed in this report.

Key Drivers in Europe Air Ambulance Services Market

The European air ambulance services market is rapidly growing on the back of various drivers. The increasing prevalence of different constant infections such as malignancy, cardiovascular sicknesses, and diabetes serves as a prominent driver to boost growth in the market. A variety of factors such as tobacco utilization, liquor, weight, and reception of stationary and undesirable ways of life are serving as crucial factors to increase the predominance of these different infections. So, on the basis of health-related crises, the European air ambulance services market is anticipated to provide efficient services.
These air ambulances are laced with required clinical arrangements. These are furnished with medical staff and clinical gear and provides clinical consideration in a flight. The non-clinical staff from the European air ambulance services market ensure convenient transportation of patients and different organs. Adaptability, security, and accommodation are some of the advantages that are provided by air ambulances. In addition to this, the increasing prevalence of illnesses is also fueling expansion opportunities in the European air ambulance services market.

The growing health disorders and illnesses among the geriatric population are also serving as key drivers to boost growth in the European air ambulance services market. Most ongoing sicknesses such as stroke and coronary illness require immediate clinical consideration. These factors are also fueling growth in the European air ambulance services market.

Get Discount on the Latest Report @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=7593

Europe Air Ambulance Services Market: Competitive Landscape

Companies operating in the air ambulance services market for Europe are indulging in collaborative partnerships to generate as much revenue as possible on the one side and maintain a strong foothold in the market competition. Besides this, players are also investing in research and development strategies to improve product and service quality and provide better medical aid for air ambulances to help patients during emergencies.

Some of the players operating in the European air ambulance services market include:
• Airbus S.A.S.
• Babcock Scandinavian Air Ambulance
• Medical Air Service
• REVA Inc.
• Airlec Air Escape
• Aero Medical Ambulance Service
• Centreline AV Limited
• Quick Air Jet Charter GmbH
• IAS Medical
• European Air Ambulance
• Aero-Dinest GmbH
• Others

Europe Air Ambulance Services Market: Notable Development

• Gainjet Ireland and REVA Inc entered into a strategic partnership to own a privately held aircraft charter management and operator firm in February 2021. The key objective is establishing a European medical center at the Shannon Airport.

Europe Air Ambulance Services Market: Drivers

The increasing pervasiveness of constant infections like diabetes, cardiovascular sicknesses, and malignancy among other persistent problems has flooded the interest for air ambulance services. Factors like the reception of undesirable and stationary ways of life, weight, liquor, and tobacco utilization, and actual inactivity are contributing to an upsurge in the predominance of these infections. For instance, according to the WHO, there are around 60 million individuals with diabetes in the European district. On the occasion of a health-related crisis, air ambulances are a crucial arrangement. They are furnished with clinical gear and staff that give clinical consideration in flight. The non-clinical staff help in transporting patients and organs. These services offer various advantages, like accommodation, security, and adaptability. Along these lines, benefits offered via air ambulances and the growing weight of ongoing illnesses are factors boosting market development.

Get Table of Content of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=7593

The increasing pervasiveness of different illnesses particularly among geriatrics is projected to arise as another key driver. Most ongoing sicknesses, like coronary illness and stroke, require quick clinical consideration. Progressed and innovative clinical consideration is given in air ambulances to patients suffering from coronary illness. Subsequently, air ambulance services are accessible to give a fast reaction in these circumstances. Increasing medical care use in Europe is additionally expected to add to the development of the market for air ambulance services.

Europe Air Ambulance Services Market: Geographical Analysis

Country-wise, the market generated an estimated 19.2% share from Germany in the year 2020 and is currently dominated by the same. This is accountable to the presence of well-established healthcare infrastructure and facilities, coupled with the increasing adoption of air ambulance services. The nation additionally has a high-level air ambulance organization, comprising essential EMS helicopters, inter-medical clinic transport, and double use helicopters. Additionally, Germany has the fourth-most elevated portion of the populace more than 65 in the OECD, with a growing number of individuals influenced by constant conditions. Coronary illness is among the significant reasons for death in Germany.

The reports offer answers to the top 7 questions that revolve around the growth of the market

• What are the diverse growth parameters influencing the market?
• Which regions will contribute largely to the growth of the market
• What are the recent innovations and technological advancements in the market?
• What are the emerging trends across the market?
• How has COVID-19 affected the market?
• What will be the post-pandemic scenario of the market?
• What are the major threats that will dent the growth prospects of the market?

Other Related Report: https://www.tmrresearch.com/air-ambulance-services-market

About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:
Rohit Bhisey
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Visit Site: https://www.tmrresearch.com/

Rohit Bhisey
TMR Research
email us here


Source: EIN Presswire

CCF Announces Partnership with Clarified Precision Medicine

Partnership to Provide Expert Precision Oncology Review for Neuroendocrine Cancer Patients

TAMPA, FL, USA, September 22, 2021 /EINPresswire.com/ — The Carcinoid Cancer Foundation (CCF) and Clarified Precision MedicineTM have partnered to offer neuroendocrine tumor (NET) patients the opportunity to receive an expert review of their tumor sequencing results from any commercially available test, e.g., FoundationOne CDx, Guardant 360, Caris MI Profile. Each patient is eligible to receive, at no cost to them, a ClarifiedSelectTM analysis, for which nationally recognized precision oncology experts provide a ranked list of FDA-approved treatments, off-label therapies, and clinical trials based on their specific tumor DNA. Every ClarifiedSelectTM report is reviewed by members of Clarified Precision Medicine’s Clinical Network to provide a clear, concise, medically-relevant summary of treatment options for patients and their physicians.

“Precision medicine has shown great potential to extend survival and improve patients’ quality of life,” explains Jody Simon, CEO of Clarified Precision MedicineTM. “Patients living with rare cancers, such as NETs, are often not prioritized and may benefit from targeted therapies. In the case of Clarified, our experts can quickly and effectively determine appropriate treatment options based on clinical experience applying tumor sequencing reports to thousands of patients over the course of their careers.”
Precision oncology is an increasingly important field of medicine which provides information that helps physicians select the best treatments for their patients utilizing genetic or molecular profiling of tumors to identify targetable alterations.

FOR PATIENTS
How the process works: NET patients submit a recently performed (within the past 2 years) tumor sequencing test from any clinical laboratory and Clarified Precision Medicine’s team of internationally-recognized experts in precision oncology will create a ClarifiedSelectTM report just for you.

What will you as a NET patient receive? You and your doctor(s) will get a ClarifiedSelectTM report that provides a ranked list of the best treatment options specifically for you based on the genetics of your tumor.

For more information about the ClarifiedSelectTM report, click here, clarifiedprecisionmedicine.com/clarifiedselect.

To receive your ClarifiedSelectTM report, visit this page and complete the easy to use request form, clarifiedprecisionmedicine.com/CarcinoidCancerFoundation.

If you have any questions, please contact Clarified Precision Medicine at clarifiedprecisionmedicine.com/contact.

Jody Simon
Clarified Precision Medicine, LLC
+1 813-477-2700
email us here


Source: EIN Presswire

Florida Mental Health Watchdog is Hosting a Course on Changes to the Baker Act

The headquarters for CCHR Florida are located in downtown Clearwater.

The headquarters for CCHR Florida are located in downtown Clearwater.

Tampa Bay area attorney and former Assistant Public Defender of the Thirteenth Judicial Circuit, Carmen Miller, Esq., is the featured speaker at the seminar on mental health rights.

Tampa Bay area attorney and former Assistant Public Defender of the Thirteenth Judicial Circuit, Carmen Miller, Esq., is the featured speaker at the seminar on mental health rights.

It was reported during the Baker Act Task Force that an estimated 30% of the children being Baker Acted in Pinellas County alone did not meet the criteria.

It was reported during the Baker Act Task Force that an estimated 30% of the children being Baker Acted in Pinellas County alone did not meet the criteria.

As reported by the Baker Act Reporting Center, more than involuntary psychiatric examinations were initiated on children across the state.

As reported by the Baker Act Reporting Center, more than 37,000 involuntary psychiatric examinations were initiated on children across the state.

Delivered by an attorney, the course covers basic rights impacted by the mental health law and involuntary psychiatric examination.

A change has finally been made but now it is imperative that this change is understood by those given the power to send a child for an involuntary psychiatric examination.”

— Diane Stein, President CCHR Florida

CLEARWATER, FLORIDA, UNITED STATES, September 22, 2021 /EINPresswire.com/ — Earlier this year the Southern Poverty Law Center (SPLC) released an alarming report. Titled “Costly and Cruel” this report revealed the abusive use of Florida’s mental health law commonly known as the Baker Act. This law allows for individuals of any age, including children, to be taken into custody for an involuntary psychiatric examination and transported to a facility for evaluation, often by law enforcement and in handcuffs. [1]

As reported by the Interim Deputy Legal Director for Children’s Rights with the SPLC, “More than 37,000 times each year, children across the state have the Baker Act used against them largely by schools, police and foster care facilities. Sometimes – for even very minor infractions and normal adolescent behavior – they are handcuffed by police, taken in cop cars and deeply traumatized as they are carted off for days at a time to psychiatric facilities for an involuntary psychiatric exam, where they may or may not get to speak with their family.” [2]

While the Florida Legislature made changes to how the Baker Act can be used in schools during the 2021 session, now requiring parental notification before a child can be taken into custody, the changes are still often misunderstood and misused prompting the Florida chapter of the Citizens Commission on Human Rights to offer workshops on the mental health law.

“Our organization has been raising awareness on this human rights abuse for years and asking lawmakers to amend the law to protect children and families,” stated the President for CCHR Florida, Diane Stein. “After several scathing investigative news stories and other organizations joining the cause a change has finally been made but now it is imperative that this change is understood by those given the power to send a child for an involuntary psychiatric examination.”

The workshop is delivered by attorney Carmen Miller, a former assistant public defender in the Thirteenth Circuit in Tampa, who has an extensive background in dealing with Baker Acts. Hosted by CCHR, the event covers the context and intentions of the mental health law, basic human rights impacted by the Baker Act, changes to the Baker Act process for children and the unintended consequences of involuntary psychiatric examinations. The next complimentary virtual event, designed for mental health professionals, attorneys and law enforcement, is scheduled for Saturday, October 16th, 2021 from 1:00 PM to 2:30 PM. To learn more or to reserve a spot, please call 727-442-8820 or send an email to execdir@cchrflorida.org.

About CCHR: Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. L. Ron Hubbard, founder of Scientology, first brought psychiatric imprisonment to wide public notice: “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health,’” he wrote in March 1969.

Sources:
[1] Costly and Cruel: Thousands of Florida children suffer the harm and indignity of involuntary, and often illegal, commitment to psychiatric facilities https://www.splcenter.org/news/2021/03/24/costly-and-cruel-thousands-florida-children-suffer-harm-and-indignity-involuntary-and-often
[2] Ibid.

Diane Stein
Citizens Commission on Human Rights of Florida
+1 727-422-8820
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

A Stand for Rights in the Sunshine State: Voices for Humanity – Diane Stein, President CCHR Florida


Source: EIN Presswire

World Alzheimer's Day, Celebrity Yoga Instructor And Caretaker, Robin Downes Shows How Yoga Can Help Those With Dementia

Robin Downes, alongside her father, demonstrates the ways that yoga can improve cognition and focus for people suffering from dementia

LOS ANGELES, CA, UNITED STATES, September 21, 2021 /EINPresswire.com/ — World Alzheimer's Day is September 21st, and Robin Downes, Emmy Award winning yoga instructor and founder of Yoga Flava™, is celebrating by teaching caregivers and sufferers of dementia how they can use yoga to combat this widespread condition. In her recent web series episode, "Caregivers Embracing Eldercare," Robin meets with doctors and experienced caregivers to discuss the reality of being a caregiver and provide support along with ideas for ways to better care for the elderly.

"Caregivers Embracing Eldercare," which can be viewed on Yoga Flava's YouTube channel, serves as the first installment of season 2 of Robin's live series. The entire series is streamed on Robin's private Facebook group, "Caregivers Embracing Eldercare." The Facebook page is a support group for caregivers who work with elderly patients. Robin hosts live sessions every Sunday where she discusses "the challenges of modern day elder care." She brings on a variety of guests that share their own caregiving experiences and share unique methods of healing. Robin and her father, Sergeant Major William Downes, do simple, accessible yoga poses to help improve concentration, recall, and overall wellbeing for her father and herself. Being a caregiver is mentally taxing, and yoga can be equally as beneficial for the caretaker as it is for the elderly patient.

Following the release of this episode, Robin is gearing up for the premiere of her documentary, Yoga Flava: The Silva Lining. The documentary takes a closer look at Robin's emergence into her role as a caregiver and how she has embraced this challenge. Robin and her father share their story and give the viewer a firsthand look at the ways that yoga has improved her father's health as well as her relationship with him. The trailer for the documentary, which is set to release in 2022, is currently available on the Yoga Flava YouTube channel, along with countless videos on yoga, caregiving, and everything in between.

Robin Downes will also be doing a special pop-up event at the Mazatlán Jazz Festival from October 8-11 as part of her 25th anniversary celebration. The event will be a one-of-a-kind yoga experience taught by Robin Downes herself. The relaxing class is being held at Pueblo Bonito Emerald Bay Resort & Spa, a venue perfect for an afternoon of relaxation and healing. Tickets are currently available on the Mazatlán Jazz Festival website, with a wide variety of packages to choose from.

About Yoga Flava™

Yoga Flava™ is a yoga company founded by Robin Downes with the goal of blending ancient yoga practices with urban culture and modern music. Robin Downes is a certified yoga instructor with 25 years of experience and a client list boasting several Hollywood stars. Anyone can experience Yoga Flava™ across multiple platforms, including the blog, newsletter, YouTube channel, and virtual classes. This year Yoga Flava™ celebrates its 25th anniversary, and Downes invites everyone to partake in the celebration through a variety of special events. Website: www.YogaFlava.com YouTube: www.youtube.com/YogaflavaTV lnstagram: https://www.instagram.com/yogaflava/

For interview requests and press reception, contact Lynn Allen Jeter & Associates or (323) 420-6575 at lajass365@gmail.com

Bailey Katler
Lynn Allen Jeter and Associates
+1 323-933-8007
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Generic Injectable Market 2021, Growth Rate, Statics, Business Opportunity and Forecast By 2026

SHERIDAN, WYOMING, UNITED STATES, September 22, 2021 /EINPresswire.com/ — The latest report by IMARC Group, titled “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” finds that the global generic injectables market size is witnessing moderate growth. Generic injectables consist of the same active ingredients as that of their branded counterparts. They also offer similar active therapeutic effects, strength, quality, performance, intended usage, and dosage. Injectables help in the easy transportation of drugs directly into the body in liquid form, which reduces the frequency of dosage administration without affecting the effectiveness of the treatment. They also do not require extensive investments, resulting in limited price erosion and significantly high-profit margins for manufacturers.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request for a free sample copy of this report: https://www.imarcgroup.com/generic-injectables-market/requestsample

Global Generic Injectables Market Trends:

The global generic injectables market is primarily driven by their growing preference over oral counterparts as they are preferred by patients who are unable to take medicines by mouth and have poor intestinal absorption. Apart from this, governments across various countries are supporting the manufacturing of generic injectables to reduce the overall cost for healthcare providers and patients. Besides this, the increasing prevalence of chronic diseases like diabetes, cardiovascular disorders, and Alzheimer’s, especially among the geriatric population, and the rising shortage of drugs are significantly contributing to the market growth. Furthermore, several key players are engaging in acquisitions and focusing on research and development (R&D) activities to develop complex and differentiated products. For instance, Agila Injectables have been acquired by Mylan Inc. from Strides Arcolab Limited to expand their existing product portfolio. On account of these factors, the market value is expected to reach US$ 445.3 Billion by 2026, exhibiting a CAGR of 7.11% during the forecast period (2021-2026).

Buy full report with table of contents: https://www.imarcgroup.com/generic-injectables-market

Key Market Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Hospira, Inc. (Pfizer Inc.)
• Fresenius Kabi AG
• Hikma Pharmaceuticals PLC
• Sandoz (Novartis)
• Sagent M&C, LLC
• Sanofi S.A.
• Baxter International, Inc.

Breakup by Therapeutic Area:
• Oncology
• Anaesthesia
• Anti-infectives
• Parenteral Nutrition
• Cardiovascular

Breakup by Container:
• Vials
• Ampoules
• Premix
• Prefilled Syringes

Breakup by Distribution Channel:
• Hospitals
• Retail Pharmacy

Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:
• Market Performance (2015-2020)
• Market Outlook (2021-2026)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Other Reports by IMARC Group:

Refrigerated Transport Market: https://www.imarcgroup.com/refrigerated-transport-market

Chemical Logistics Market: https://www.imarcgroup.com/chemical-logistics-market

Power Transistors Market: https://www.imarcgroup.com/power-transistors-market

Baby Cribs and Cots Market: https://www.imarcgroup.com/baby-cribs-cots-market

Cervical Cancer Diagnostics Market: https://www.imarcgroup.com/cervical-cancer-diagnostics-market

Amino Acids Market: https://www.imarcgroup.com/amino-acid-technical-material-market-report

Interior Architectural Coatings Market: https://www.imarcgroup.com/interior-architectural-coatings-market

Fixed Satellite Services Market: https://www.imarcgroup.com/fixed-satellite-services-market

Television Advertising Market: https://www.imarcgroup.com/television-advertising-market

Electric Lawn Mower Market: https://www.imarcgroup.com/electric-lawn-mower-market

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here


Source: EIN Presswire

Generic Drugs Market Analysis Report 2021-2026: Industry Growth, Trends, Business Strategy, and Forecast

SHERIDAN, WYOMING, UNITED STATES, September 22, 2021 /EINPresswire.com/ — According to the latest report by IMARC Group, titled "Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026", the global generic drugs market size reached a value of US$ 386 Billion in 2020. Looking forward, the market value is projected to reach US$ 517 Billion by 2026, expanding at a CAGR of 4.9% during the forecast period (2021-2026).

Generic drugs are identical to branded drugs in terms of safety, dosage, form, strength, quality, performance, characteristics, and route of administration. They have the same active ingredients, offer an equivalent therapeutic effect and are proven safe as the branded drug. They are also cost-effective as manufacturers do not have to invest in research and development (R&D) and marketing activities. At present, generic drugs are gaining immense popularity across the world.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request for a free sample copy of this report: https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample

Global Generic Drugs Market Trends:

The rising prevalence of chronic diseases, such as dyslipidemia, diabetes, hypertension, and metabolic syndrome, on account of sedentary lifestyles, hectic work schedules and changing dietary patterns, have increased the uptake of medicines across the world. This represents one of the primary factors facilitating the global generic drugs market growth. Additionally, the rising patent expiration of branded drugs, in confluence with increasing initiatives by governing authorities, is encouraging key manufacturers to introduce effective generic drugs, which, in turn, is significantly contributing to the market growth. For instance, seven hospitals and three philanthropies in the United States launched a generic drug company named Civica Rx in 2018 to address the shortage of drugs and the high cost of essential medication, producing fourteen short-supply, FDA-approved drugs.

Buy full report with table of contents: https://www.imarcgroup.com/generic-drug-manufacturing-plant

Key Market Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Teva Pharmaceuticals Industries Ltd.
• Mylan N.V.,
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Fresenius SE & Co
• Lupin Limited
• Endo Pharmaceuticals Inc.
• Aurobindo Pharma Limited
• Aspen Pharmacare Holdings Limited

Breakup by Therapy Area:
• Central Nervous System
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

Breakup by Drug Delivery:
• Oral
• Injectables
• Dermal/Topical
• Inhalers

Breakup by Distribution Channel:
• Retail Pharmacies
• Hospital Pharmacies

Regional Insights:
• United States
• China
• Brazil
• Germany
• France
• India
• United Kingdom
• Japan
• Canada
• Italy
• Others

Key highlights of the report:
• Market Performance (2015-2020)
• Market Outlook (2021- 2026)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Other Reports by IMARC Group:

Online Food Delivery Packaging Market: https://www.imarcgroup.com/online-food-delivery-packaging-market

Pepperoni Market: https://www.imarcgroup.com/pepperoni-market

Operational Intelligence Market: https://www.imarcgroup.com/operational-intelligence-market

Military Vertical Take-off and Landing Aircraft Market: https://www.imarcgroup.com/military-vertical-take-off-landing-aircraft-market

Tenosynovial Giant Cell Tumor Treatment Market: https://www.imarcgroup.com/tenosynovial-giant-cell-tumor-treatment-market

Global Ghee Market: https://www.imarcgroup.com/ghee-market

Low Voltage Electric Motor Market: https://www.imarcgroup.com/electric-motor-manufacturing-plant

Industrial Wearable Devices Market: https://www.imarcgroup.com/industrial-wearable-devices-market

Liquid Detergent Market: https://www.imarcgroup.com/liquid-detergent-market

Exterior Sheathing Market: https://www.imarcgroup.com/exterior-sheathing-market

Elena Anderson
IMARC Services Private Limited
+1 631-791-1145
email us here


Source: EIN Presswire

Digital PCR Market to Hit $1.05 Billion by 2027 at 12.3% CAGR

Digital PCR Market

Digital PCR Market

An increase in prevalence of infectious diseases & cancer and surge in awareness & acceptance of personalized medicines drive the growth of digital PCR market

PORTLAND, OR, UNITED STATES, September 22, 2021 /EINPresswire.com/ — Allied Market Research published a report, titled, “Digital PCR Market by Treatment Type (Droplet Digital PCR and BEAMing Digital PCR), Product Type (Digital PCR Systems, Consumables & Reagents, and Software & Services), Application (Research, Clinical Diagnostics, and Forensic & Others), and End User (Pharmaceuticals & Biotechnology Industries, Clinical Diagnostic Laboratories, and Universities & Other Organizations): Opportunity Analysis and Industry Forecast, 2020–2027.” According to the report, the global digital polymerase chain reaction industry garnered $398.50 million in 2019, and is estimated to reach $1.05 billion by 2027, witnessing a CAGR of 12.3% from 2020 to 2027.

Increase in prevalence of infectious diseases & cancer and surge in awareness & acceptance of personalized medicines drive the growth of the global digital PCR market. However, high initial cost and reimbursement issues hinder the market growth. On the other hand, technological advancements and surge in funding in R&D activities present new opportunities in the coming years.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/654

Covid-19 Scenario

There has been surge in utilization of the ddPCR technology along with the launch of new ddPCR assays for the detection of coronavirus. This is due to its advantages such as high sensitivity of ddPCR, lack of inhibition from sample types, and ease in understanding the results.
The demand for digital PCR increased and R&D activities gained traction for determining the role of dPCR over quantitative polymerase chain reaction (qPCR) for Covid-19 testing.
Many leading market players acquired the U.S. Food and Drug Administration (FDA) Emergency Use Authorization for the dPCR test kits for fulfilling the considerable increase in demand.
The droplet digital PCR segment to maintain its highest contribution during the forecast period

Based on technology, the droplet digital PCR segment contributed to the lion’s share, accounting for more than 90% of the global digital PCR market in 2019, and will maintain its highest contribution during the forecast period. This is due to precise measurement of DNA molecules through each drop and massive sample partitioning provided by this technology. However, the beaming PCR segment is projected to manifest the highest CAGR of 14.2% from 2020 to 2027. This is attributed to high sensitivity to assist in identification and quantification of specific somatic mutations present in the DNA.

Based on application, the clinical diagnostics segment held the largest share in 2019, contributing to more than two-fifths of the global digital PCR market, and is expected to maintain its leadership position throughout the forecast period. This is attributed to increase in incidence of infectious diseases and rise in number of cancer patients across the globe. However, the forensics and others segment is estimated to witness the fastest CAGR of 13.7% during the forecast period, owing to high and regular usage of digital PCR in forensic science and assisted reproduction, in which the analysis of genetic material from one or few cells is needed.

Based on region, North America accounted for the largest market share in 2019, holding nearly half of the global digital PCR market, and will continue its lead position in terms of revenue by 2027. This is attributed to well-developed healthcare sector, presence of leading molecular diagnostics manufacturers, and surge in number of patients using personalized medicines in the region. However, Asia-Pacific is projected to manifest the largest CAGR of 14.8% from 2020 to 2027, owing to surge in number of patients suffering from chronic diseases and improved healthcare facilities in the region.

Leading market players

4basebio AG
Bio-Rad Laboratories, Inc.
Fluidigm Corporation
Combinati, Inc.
JN Medsys
Merck KGaA
Qiagen N.V.
Stilla Technologies
Sysmex Corporation
Thermo Fisher Scientific, Inc.

Know More : https://www.alliedmarketresearch.com/digital-polymerase-chain-reaction-market

Trending Reports:
Cardiovascular & Soft Tissue Repair Patches Market– Global Opportunity Analysis and Industry Forecasts
Cardiovascular Digital Solutions Market– Global Opportunity Analysis and Industry Forecast
Marine Derived Pharmaceuticals Market– Opportunity Analysis and Industry Forecast

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Cannabis Testing Market is Like to Reach $2.4 Billion by 2027

Cannabis Testing

Cannabis Testing

Cannabis Testing Market: Global Opportunity Analysis and Industry Forecast, 2019–2027

PORTLAND, OR, UNITED STATES, September 22, 2021 /EINPresswire.com/ — Cannabis refers to a group of three plants with psychoactive properties, known as Cannabis sativa, Cannabis indica, and Cannabis ruderalis. When the flowers of these plants are harvested and dried, it is left with one of the most common drugs in the world. Some call it weed, some call it pot, and others call it marijuana. Cannabis is usually consumed for its relaxing and calming effects. Cannabis testing includes use of several medical instruments, consumable, and software to detect the quality of cannabis. This helps to identify the quality of cannabis for several medical purposes. Previously, both cultivation and sales of cannabis were banned across the globe for several years. Now, many countries are recognizing the benefits of cannabis for medicinal purposes and rescinding their ban.

According to a new report published by Allied Market Research, titled, “Cannabis Testing Market by Product, Test Type, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2027,” The global cannabis testing market was valued at $ 1,029 million in 2019, and is projected to reach $2,445 million by 2027, registering a CAGR of 11.9%.

Click Here To Access Sample Report @ https://www.alliedmarketresearch.com/request-sample/11264

Impact of the pandemic and slowing global research activities have also had a negative impact on the operations and financial performance of many players in the cannabis testing market. The shutting down of academic & research institutes and testing laboratories led to a decline in the number of cannabis tests performed in the laboratories. For instance, according to an article published by MJBizDaily in March 2020, most of the federally regulated cannabis labs in Canada are supporting COVID-19 testing, which subsequently had an impact on the number of cannabis tests performed in the labs.

The cannabis market lost some revenue due to factors such as testing laboratory closures, disrupted supply chains, general economic slowdown, and restricted movement. In addition, numerous market players providing products and software to the cannabis testing industry witnessed a decline in the sales of instruments and consumables due to the shutdown of labs, declining number of cannabis tests performed, and certain restrictions on the import and export of cannabis testing products. These factors led to a decline in the sales of consumables & instruments used in the cannabis testing industry, thereby hampering the growth of the cannabis testing market. This was majorly due to the decline in the purchase of products, subsequently impacting the growth of the products and consumables segment of the cannabis testing industry.

The cannabis testing market is witnessing rapid growth due to growing legalization of medical marijuana (especially in the U.S.), funding initiatives for cannabis testing laboratories, and the growing number of cannabis cultivators, cannabis drug manufacturers, & testing laboratories, which are contributing to the growth of the cannabis testing market. However, variations in cannabis testing methods and lack of testing regulations are expected to restrain the growth of the market. Conversely, emerging economies across developing regions, such as LATAM and Asia-Pacific, are expected to provide new opportunities for market players in future.

The key companies profiled in the report include Agilent Technologies Inc., Danaher Corporation, Merck KGAA, PerkinElmer, Restek Corporation, SC Laboratories, Shimadzu Corporation, Steep Hill, Thermo Fisher Scientific, and Waters Corporation.

Key Findings Of The Study
• By product, the consumables segment occupied 59% market share of the global cannabis testing market in 2019.
• On the basis of test type, the potency testing segment is anticipated to grow with the highest CAGR over the forecast period.
• Region-wise, the LAMEA cannabis testing market is anticipated to exhibit a CAGR of 14.1% during the forecast period.

North America accounted for the largest share of revenue in 2019, and is anticipated to maintain its dominance from 2020 to 2027, owing to legalization of cannabis (especially in the U.S.) and the growing ease of availability of instruments, software, and services for cannabis testing, which are driving the growth of the North American cannabis testing market. However, LAMEA is expected to grow at the highest CAGR, owing to increasing number of cannabis cultivators, rising number of testing laboratories, and legalization of cannabis for medical use.

Know More @ https://www.alliedmarketresearch.com/cannabis-testing-market-A10899

We have also published few syndicated market studies in the other trending area that might be of your interest. Below are the report title for your reference, considering the Impact of Covid-19 over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

Trending Reports:
Sartans Market– Global Opportunity Analysis and Industry Forecasts
Trisenox Market– Global Opportunity Analysis and Industry Forecast
Anal Fistula Treatment Market– Opportunity Analysis and Industry Forecast

David Correa
Allied Analytics LLP
email us here
+1 503-894-6022
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Broadstep Behavioral Health acquires Coastal Southeastern United Care

Lynn Mason, President & CEO, Broadstep Behavioral Health

RALEIGH, NORTH CAROLINA , USA , September 22, 2021 /EINPresswire.com/ — Broadstep Behavioral Health, serving individuals with intellectual and developmental disabilities and severe persistent mental illness, has acquired Coastal Southeastern United Care. Coastal (CSEUC) is a behavioral health and substance abuse agency providing a wide range of diagnostic and treatment programs in North and South Carolina. Broadstep, a portfolio company of Bain Capital’s Double Impact fund, operates in seven states and is headquartered in Raleigh.

“We are pleased to welcome Coastal team members and the individuals they serve into the Broadstep family,” said Lynn Mason, Broadstep’s President and CEO. “Together, we look forward to addressing the many challenges facing behavioral healthcare and continuing to improve the lives of people with intellectual and developmental disabilities.”

Established in 2010 and based in Brunswick County, North Carolina, CSEUC is a Critical Access Behavioral Health Agency providing a continuum of community-based behavioral health and substance abuse services for adults, adolescents, and children. Nationally accredited by the Commission on Accreditation of Rehabilitative Healthcare, CSEUC currently serves ten North Carolina counties (Bladen, Brunswick, Cleveland, Columbus, Gaston, Lincoln, New Hanover, Pender, Robeson, and Scotland), and Dillon County in South Carolina.

“The core values of the Coastal Southeastern United Care team include accountability, integrity, innovation, and commitment to the communities we serve,” said Stacy Williamson, CEO and former co-owner of CSEUC. “Our employees derive their commitment and dedication from years of providing excellent service. We have witnessed clinical outcomes of our services and have seen how they positively impact people’s lives and our communities.”

“Coastal has worked diligently in our communities and within our walls to change perceptions of mental health and to promote understanding and compassion for the individuals we serve,” said Kelly Williamson, former co-owner. “We meet the individuals where they are, assist them to live as independently as possible, reunify with their families, and serve as a resource to fill in the gaps. It’s education. It’s working together.”

The need for increased mental health and substance abuse services is compelling. The latest data from the National Alliance on Mental Illness reports that only half (50.6%) of US youth ages 6-17 with mental health disorders received treatment. The numbers were more discouraging for US adults, with just 44.8% receiving treatment. Furthermore, nearly one in five adults in the US with mental illness experienced co-occurring disorders with substance abuse (9.5 million individuals).

About Broadstep Behavioral Health
Founded in Wisconsin in 1972, Broadstep Behavioral Health provides a continuum of physical, emotional, and mental support for children and adults with intellectual and developmental disabilities (I/DD), mental illness, and co-occurring disorders. Broadstep offers a range of support programs, including residential group homes, specialized schools for children, and vocational and day programs that help foster life skills development and realize social and professional potential. Broadstep Behavioral Health operates in seven states (Illinois, Indiana, New Jersey, Nebraska, North Carolina, South Carolina, and Wisconsin). Visit www.broadstep.com to learn more.

About Bain Capital Double Impact (BCDI)
Bain Capital Double Impact is the impact investing strategy of Bain Capital, a leading global private investment firm. Applying Bain Capital’s value-added approach to impact investing, BCDI partners with companies to scale their growth and impact to solve critical social problems alongside a financial return. BCDI’s areas of focus are health and wellness, sustainability, and education and workforce development. BCDI was named 2020’s Global Impact Investment Fund of the Year by London-based Private Equity International. Visit www.BainCapitalDoubleImpact.com to learn more.

Contact:
John Tote, VP of Business Development
Broadstep Behavioral Health
jtote@broadstep.com
919-219-3944

Permission granted for redistribution
#Broadstep #BehavioralHealth #CSEUC #CoastalSoutheasternUnitedCare #BainCapital #NorthCarolina #SouthCarolina #IntellectualDevelopmentalDisabilities #IDD #Autism #MentalIllness #LynnMason #DoubleImpactFund #JohnTote #ImpactFund #BrunswickCounty #SubstanceAbuse #NAMI

Robert Butler – Communications & Public Relations – www.RBButler.com

Citations: https://www.nami.org/mhstats

Robert B Butler – Communications | PR
North Carolina Press Release
919-455-8345
email us here


Source: EIN Presswire

Spirulina Market Like to Cross $897.61 Million by 2027

Spirulina Industry

Spirulina Industry

Spirulina Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

PORTLAND, OR, UNITED STATES, September 22, 2021 /EINPresswire.com/ — According to the report published by Allied Market Research, the global spirulina market garnered $393.6 million in 2019, and is expected to reach $897.61 million by 2027, witnessing a CAGR of 10.5% from 2020 to 2027. The report provides an extensive analysis of changing market dynamics, key segments, value chain, top investment pockets, regional landscape, and competitive scenario.

Increase in demand for natural ingredients, supportive government initiatives for production of spirulina, and R&D activities to promote spirulina as commercial products drive the growth of the global spirulina market. However, impact on production due to climate change hinders the market growth. On the other hand, untapped potential in developing countries and ease in cultivation due to development in technology create new opportunities in the coming years.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4222

Covid-19 Scenario:

The demand for spirulina increased during the Covid-19 pandemic as the focus on nutritional content rose. Researchers also focused on finding a possible role of algae in delaying the onset of Covid-19.

In addition, various studies have been carried out to determine potential of seaweed to fight Covid-19 by the organizations such as the World Health Organization (WHO).

Despite the increase in demand, there were hindrances in supply chain due to lockdown imposed by governments in many countries. The supply chain is expected to get back on track during the post-lockdown.

The report offers detailed segmentation of the global spirulina market based on type, application, formulation, and region.

Based on type, the arthrospira platensis segment held the highest market share in 2019, accounting for nearly three-fifths of the total share, and is projected to maintain its lead position during the forecast period. However, the arthrospira maxima segment is expected to witness the highest CAGR of 10.6% from 2020 to 2027.

Based on application, the nutraceuticals segment contributed to the highest market share in 2019, holding nearly three-fifths of the global spirulina market, and will maintain its dominant share in terms of revenue during the forecast period. However, the cosmetics segment is projected to portray the largest CAGR of 12.0% from 2020 to 2027.

Based on region, North America accounted for the highest market share in 2019, contributed to nearly two-fifths of the total share, and will maintain its leadership status by 2027. However, Asia-Pacific is estimated to maintain the fastest CAGR of 11.2% during the forecast period.

Leading players of the global spirulina market analyzed in the research include Cyanotech Corporation DIC Corporation, DDW, DÖHLER GmbH, Cabassi & Giuriati SpA, Echlorial, E.I.D. Dongtai City Spirulina Bio-engineering Co., Ltd., Givaudan international SA, Parry Limited, Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae Spirulina Supplies Pvt. Ltd., Pond Technologies Inc., Algenol Biofuels Inc., and Sensient Technologies Corporation.

Know More: https://www.alliedmarketresearch.com/spirulina-market

Treading Reports:
Animal Insulin Market: Global Opportunity Analysis and Industry Forecast, 2021–2030
Avian Influenza Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2021–2030
Carbinoxamine Market: Global Opportunity Analysis and Industry Forecast, 2021–2030

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire